Biofrontera (BFAGY)

Biofrontera AG operates as a biopharmaceutical company, which engages in the development, sale and distribution of dermatological drugs and medical cosmetics for the care, protection and treatment of the skin. Its products are used for the treatment of chronic, antihistamine refractory urticaria and migraine prophylaxis. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany.

BFAGY stock data


12 Apr 21
1 Jul 22
31 Dec 22
Quarter (USD) Dec 20 Dec 19 Dec 18 Dec 17
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 20 Dec 19 Dec 18 Dec 17
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
13F holders Current Prev Q Change
Total holders 2 7 -71.4%
Opened positions 0 0
Closed positions 5 0 NEW
Increased positions 1 2 -50.0%
Reduced positions 0 2 EXIT
13F shares Current Prev Q Change
Total value 148.28M 188.63M -21.4%
Total shares 30.39M 27.64M +10.0%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Deutsche Balaton Aktiengesellschaft 16.99M $62.52M +19.7%
Maruho 13.4M $85.76M 0.0%
Largest transactions Shares Bought/sold Change
Deutsche Balaton Aktiengesellschaft 16.99M +2.79M +19.7%
MS Morgan Stanley 0 -14.3K EXIT
1492 Capital Management 0 -12.61K EXIT
Citadel Advisors 0 -10.72K EXIT
UBS UBS Group AG - Registered Shares 0 -2.09K EXIT
Advisor 0 -200 EXIT
Maruho 13.4M 0 0.0%
Proequities 0 0

Financial report summary

Dusa Pharmaceuticals

Content analysis

H.S. sophomore Avg
New words: AB, ACA, adult, al, albeit, alcohol, amicable, antimicrobial, arisen, ASP, Astaro, bactericidal, Baltic, bearer, Biden, Bilanzgewinn, biocolloid, biologist, blood, brightest, Bulletin, Bundesdatenschutzgesetz, businessman, CAGR, CCPA, Chicago, CJEU, compatibility, concomitant, counteract, dead, deadline, dealt, debate, departure, Dermatest, destination, DNA, dual, dynamic, Efudex, envisioned, epidermal, ethyl, fatal, felt, female, Finland, flagship, forestry, forty, Galenica, Gesetz, grace, gyrase, Haftung, Hanseatic, headcount, Heilmittelwerbegesetz, hinder, hygiene, IIb, immune, incomplete, incremental, influenced, Inline, Insight, Inspector, Interactive, Intershop, IQVIA, isolated, Joseph, Jr, keratinization, KPMG, Linkbase, lockdown, LTI, Ludwig, Lutter, malignant, Malm, mediate, men, middle, mir, missed, mortality, mupirocin, mutate, narrowband, Nordic, NVI, ODV, OIG, online, overturned, Oxford, pattern, payer, pediatric, pension, pharmacovigilance, PhD, pillar, plant, Poet, precautionary, precursor, predecessor, premature, prematurely, Privatbank, progression, proliferate, Quinolonecarboxylic, Quirin, radiation, reaction, reauthorization, reestimated, reevaluated, reintroduction, remote, reopened, Rescue, retransfer, retransferred, reversal, reverse, rewarding, RPI, Russian, Scandinavia, scenario, Schema, sending, sharp, sharply, shorten, Societal, soft, Stewardship, STI, strep, synthetic, Taxonomy, telehealth, tentatively, thatoverall, thrive, Tirbanibulin, top, topoisomerase, uncommon, underway, undiluted, unharmed, unified, unprecedented, unsure, unusual, uptake, urgent, UV, viability, vicinity, video, Vietnam, vitro, wake, Warsaw, wave, weaken, women, XBRL, xepi®, yellowish
Removed: accrue, acted, adapted, administer, advanced, aim, AktiengesellschaftorAG, Alacare®adhesive, Allergan, Ameluz®and, Ameluz®for, Ameluz®from, Ameluz®in, Ameluz®PDT, Ameluz®to, Ameluz®were, Ameluz®with, announcement, arranged, assuming, Belgium, belief, binominal, bioavailability, Biofrontera®figurative, bleed, blind, Bowen, capitalizing, carcinomain, Caucasian, centrally, CEO, CH, Chipcard, clinically, comfort, commented, concert, constituted, consultation, core, covalently, covenant, cycle, Dawson, deadly, decarboxylase, deeply, Delaware, demonstrating, depressing, depression, determinative, die, division, documented, downturn, DRAM, Dresden, dry, easier, emitted, excluded, explore, extra, familiar, fraction, front, function, globally, gram, grew, HaftungorGmbH, Hapila, hedge, Heptagon, highlight, histidine, histological, IFRIC, IL, immunosuppressed, inactive, incidence, includinginter, incorporate, individually, Infineon, infrared, ingenol, intent, intragroup, Israeli, itchy, journal, Kapital, Kerastick, keratotic, labeled, labelling, laboratory, Lake, Lang, laser, licensee, lodging, Luxembourg, Luxerm®cream, Luxerm®in, manuscript, marketplace, match, matched, mebutate, metabolism, Metvix®are, Metvix®in, moisturize, multicenter, multinational, negotiate, observation, occasion, opposite, orally, Oy, paragraph, penetrate, photosensitizing, pivotal, plaster, Portugal, prophylactic, prospectively, prototype, Qimonda, ranged, rapidly, rejected, rejuvenating, rejuvenation, relied, renew, renewal, repurchase, researched, rounded, scaly, screening, secondary, Semiconductor, sex, Solar, soothe, stability, stratification, subdivided, successive, supersede, survive, sustained, tablet, theproduct, therewith, thicker, tolerability, toxicology, tracked, train, tranchemultiplied, Ubidyne, unattractive, uncompetitive, underestimation, underwriting, unemployment, unstable, upper, urticaria, urticarial, Vector, warming, wherewithal, yield
No filings